ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,585
0,00%
Bitcoin
60 695,13
-0,16%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Axonics Inc (AXNX)

  7. Axonics Inc (AXNX) Actualités

AXNX

Axonics (AXNX)

Axonics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AXNX
DateHeureSourceTitreSymboleSociété
30/04/202422h01Business WireAxonics Reports First Quarter 2024 Financial ResultsNASDAQ:AXNXAxonics Inc
24/04/202412h30PR Newswire (US)Boston Scientific Announces Results for First Quarter 2024NASDAQ:AXNXAxonics Inc
22/03/202421h01Business WireAxonics Stockholders Approve Merger Agreement with Boston ScientificNASDAQ:AXNXAxonics Inc
21/03/202421h54Business WireAxonics Provides Update on Inter Partes Review ProceedingsNASDAQ:AXNXAxonics Inc
14/03/202411h00Business WireAxonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation SystemNASDAQ:AXNXAxonics Inc
07/03/202423h24Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AXNXAxonics Inc
29/02/202422h01Business WireAxonics Responds to ITC Action by MedtronicNASDAQ:AXNXAxonics Inc
28/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXNXAxonics Inc
28/02/202422h01Business WireAxonics Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:AXNXAxonics Inc
22/02/202414h00Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AXNXAxonics Inc
03/02/202400h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
31/01/202412h30PR Newswire (US)Boston Scientific Announces Results for Fourth Quarter and Full Year 2023NASDAQ:AXNXAxonics Inc
10/01/202421h07PR Newswire (US)Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law FirmNASDAQ:AXNXAxonics Inc
08/01/202423h19Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AXNXAxonics Inc
08/01/202422h55PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.NASDAQ:AXNXAxonics Inc
08/01/202417h36Dow Jones NewsAxonics Shares Climb 20% After Acquisition by Boston ScientificNASDAQ:AXNXAxonics Inc
08/01/202413h41Dow Jones NewsBoston Scientific To Acquire Axonics For About $3.7 BillionNASDAQ:AXNXAxonics Inc
08/01/202413h00PR Newswire (US)Boston Scientific Announces Agreement to Acquire Axonics, Inc.NASDAQ:AXNXAxonics Inc
08/01/202413h00Business WireAxonics Announces Definitive Agreement to be Acquired by Boston ScientificNASDAQ:AXNXAxonics Inc
08/01/202413h00Business WireAxonics Reports Preliminary 4Q23 and Fiscal Year 2023 RevenueNASDAQ:AXNXAxonics Inc
27/12/202322h01Business WireAxonics to Present at the J.P. Morgan Healthcare ConferenceNASDAQ:AXNXAxonics Inc
26/12/202319h31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXNXAxonics Inc
06/11/202318h00GlobeNewswire Inc.Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual DisabilitiesNASDAQ:AXNXAxonics Inc
01/11/202311h00Business WireAxonics to Participate in November Investor ConferencesNASDAQ:AXNXAxonics Inc
30/10/202321h01Business WireAxonics Reports Third Quarter 2023 Financial ResultsNASDAQ:AXNXAxonics Inc
07/10/202302h04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
04/10/202301h32Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AXNXAxonics Inc
02/10/202312h00Business WireAxonics to Report Third Quarter 2023 Financial Results on October 30NASDAQ:AXNXAxonics Inc
25/08/202312h00Business WireAxonics to Participate in September Investor ConferencesNASDAQ:AXNXAxonics Inc
21/08/202312h00Business WireAxonics Announces CFO Retirement and Appoints SuccessorNASDAQ:AXNXAxonics Inc
 Showing the most relevant articles for your search:NASDAQ:AXNX

Dernières Valeurs Consultées

EU
ORA
Orange
NASDAQ
AMZN
Amazon.com
NASDAQ
NVDA
NVIDIA
EU
ACA
Credit Agricole
EU
MC
Lvmh Moet Hennessy Louis...
EU
VIV
Vivendi
NASDAQ
AAPL
Apple
EU
CAP
Capgemini
NYSE
MRK
Merck
EU
GLE
Societe Generale
NYSE
NKE
Nike
EU
RNO
Renault
EU
RI
Pernod Ricard
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés